bisoprolol has been researched along with Cardiac Output, Low in 11 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Cardiac Output, Low: A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Trimetazidine was given in a dose 20 mg 3 times a day." | 2.71 | [Clinical and hemodynamic efficacy of selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease]. ( Fedorova, TA; Il'ina, IuV; Loshchits, NV; Rybakova, MK; Sotnikova, TI, 2004) |
| "Bisoprolol was well tolerated without between group difference in premature treatment withdrawals (82 on placebo, 75 on bisoprolol; NS)." | 2.67 | A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. ( , 1994) |
| "A couple of days after increasing the dosage of betaadrenergic- and adding calcium channel blockers due to an increased heart rate in atrial fibrillation, a 77 year old female was found in cardiogenic shock." | 1.38 | [The choked heart]. ( Furrer, F; Giambarba, C, 2012) |
| " All centres were provided with carvedilol, metoprolol, and bisoprolol at appropriate doses; the choice of the drug and dosage was left to the responsible clinician." | 1.32 | Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience. ( Balli, E; Geraci, E; Gorini, M; Gronda, E; Lucci, D; Maggioni, AP; Opasich, C; Sinagra, G; Tavazzi, L; Tognoni, G, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (63.64) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furrer, F | 1 |
| Giambarba, C | 1 |
| Maggioni, AP | 1 |
| Sinagra, G | 1 |
| Opasich, C | 1 |
| Geraci, E | 1 |
| Gorini, M | 1 |
| Gronda, E | 1 |
| Lucci, D | 1 |
| Tognoni, G | 1 |
| Balli, E | 1 |
| Tavazzi, L | 2 |
| Mahmoudi, M | 1 |
| McDonagh, S | 1 |
| Poole-Wilson, P | 1 |
| Dubrey, SW | 1 |
| Fedorova, TA | 1 |
| Il'ina, IuV | 1 |
| Sotnikova, TI | 1 |
| Rybakova, MK | 1 |
| Loshchits, NV | 1 |
| Günnicker, M | 1 |
| Freund, U | 1 |
| Grebe, EJ | 1 |
| Scherer, R | 1 |
| Schieffer, M | 1 |
| Zerkowski, HR | 1 |
| Hess, W | 1 |
| Levy, P | 1 |
| Lechat, P | 2 |
| Leizorovicz, A | 1 |
| Levy, E | 1 |
| Yudkin, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Collaborative Systematic Overview of Randomised Controlled Trials of Beta-Blockers in the Treatment of Heart Failure[NCT00832442] | 18,240 participants (Anticipated) | Observational | 2008-08-31 | Enrolling by invitation | |||
| Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for bisoprolol and Cardiac Output, Low
| Article | Year |
|---|---|
Beta-blocker treatment in heart failure. Role of heart rate reduction.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Cardiac Output, Low; Heart Rate; Humans; Prognosis; Randomi | 1998 |
4 trials available for bisoprolol and Cardiac Output, Low
| Article | Year |
|---|---|
[Clinical and hemodynamic efficacy of selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Bisoprolol; Cardiac Output, Low; Drug A | 2004 |
A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Cardiac Output, Low; Cardiomyopathy, Dilated; Dose-Response | 1994 |
Design of the cardiac insufficiency bisoprolol study II (CIBIS II). The CIBIS II Scientific Committee.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Bi | 1997 |
A cost-minimization of heart failure therapy with bisoprolol in the French setting: an analysis from CIBIS trial data. Cardiac Insufficiency Bisoprolol Study.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Cardiac Output, Low; Cost-Benefit Analysis; Double-Blind Me | 1998 |
6 other studies available for bisoprolol and Cardiac Output, Low
| Article | Year |
|---|---|
[The choked heart].
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Bisoprolol; Calcium Channel Blockers; Cardia | 2012 |
Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Cardiac Output, Low; Carvedilol; Chronic | 2003 |
Obstacles to the initiation of beta blockers for heart failure in a specialised clinic within a district general hospital.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Ambulatory Care; Bisoprolol; Cardiac Ou | 2003 |
[Effect of dopexamine on the hemodynamics of coronary surgery patients with and without bisoprolol blockade].
Topics: Adrenergic beta-Agonists; Adult; Aged; Bisoprolol; Cardiac Output, Low; Coronary Artery Bypass; Coro | 1993 |
[Practical advice on the treatment of cardiac insufficiency with beta-blockers. Announcement by the Italian Association of Hospital-based Cardiologists].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Cardiac Output, Low; Drug Administration Schedule; Heart Fa | 1999 |
Beta-blockers in heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Cardiac Output, Low; Diabetes Mellitus, Type 2; Education, | 1999 |